of 12
8/12/2019 An Alternative to Fish Oils Metabolic Engineering of Oil-seed Crops to Produce
1/12
Review
An alternative to fish oils: Metabolic engineering of oil-seed crops to produceomega-3 long chain polyunsaturated fatty acids
Mnica Venegas-Calern a,b, Olga Sayanova a, Johnathan A. Napier a,*
a Department of Biological Chemistry, Rothamsted Research, Harpenden, Herts AL5 2JQ, UKb Instituto de la Grasa, CSIC, Av. Padre Garcia Tejero 4, E-41012 Seville, Spain
a r t i c l e i n f o
Article history:
Received 17 September 2009
Received in revised form 13 October 2009
Accepted 20 October 2009
Keywords:
Polyunsaturated fatty acids
Plants
Omega-3 fatty acids
Desaturases
Elongases
Transgenic plant
a b s t r a c t
It is now accepted that omega-3 polyunsaturated fatty acids, especially eicosapentaenoic acid (EPA;
20:5D5,8,11,14,17) and docosahexaenoic acid (DHA, 22:6D4,7,10,13,16,19) play important roles in a
number of aspects of human health, with marine fish rich in these beneficial fatty acids our primary die-
tary source. However, over-fishing and concerns about pollution of the marine environment indicate a
need to develop alternative, sustainable sources of very long chain polyunsaturated fatty acids (VLC-
PUFAs) such as EPAand DHA. A number of different strategies have been considered, with one of the most
promising being transgenic plants reverse-engineered to produce these so-called fish oils. Considerable
progress has been made towards this goal and in this review we will outline the recent achievements in
demonstrating the production of omega-3 VLC-PUFAs in transgenic plants. We will also consider how
these enriched oils will allow the development of nutritionally-enhanced food products, suitable either
for direct human ingestion or for use as an animal feedstuff. In particular, the requirements of aquacul-
ture for omega-3 VLC-PUFAs will act as a strong driver for the development of such products. In addition,
biotechnological research on the synthesis of VLC-PUFAs has provided new insights into the complexities
of acyl-channelling and triacylglycerol biosynthesis in higher plants.
2009 Elsevier Ltd. All rights reserved.
Contents
1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
2. Omega-3 long chain polyunsaturated fatty acids (x3 LC-PUFAs) in humans health. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1093. Characterization of VLC-PUFAs biosynthetic pathways . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
4. Metabolic engineering to produce VLC-PUFAs in higher plants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
5. Crucial issues: optimization the levels of LC-PUFA in transgenic plants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
5.1. The identification of superior desaturases. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
5.2. Identification of a VLC-PUFA-specific acyl-exchange mechanism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
5.3. Maintenance of a continuous flux of substrates through the VLC-PUFA biosynthetic pathway without significant loss to TAG . . . . . . . 115
5.4. Optimizing the fatty acid elongase. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
5.5. Modulating the acyl-CoA pool . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
5.6. Co-ordinated expression of transgenes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
5.7. Appropriate localisation of transgene-derived activities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1166. Conclusions and future perspectives. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
0163-7827/$ - see front matter 2009 Elsevier Ltd. All rights reserved.doi:10.1016/j.plipres.2009.10.001
Abbreviations: ALA, a-linolenic acid; ARA, arachidonic acid; DAG, diacylglycerol; DGAT, diacylgylcerol acyltransferase; DHA, docosahexaenoic acid; ECR, enoyl-CoAreductase; EFA, essential fatty acid; EPA, eicosapentaenoic acid; GLA, c-linolenic acid; HCD, hydroxyacyl-CoA dehydratase; KCS, ketoacyl-CoA synthase; KCR, b-ketoacyl-CoAreductase; LA, linoleic acid; LPCAT, acyl-CoA: lyso-phosphatidylcholine acyltransferase; PDAT, phospholipid: diacylglycerol acyltransferase; SDA, stearidonic acid; TAG,
triacylglycerol; VLC-PUFA, very long chain polyunsaturated fatty acid.
* Corresponding author. Tel.: +44 (0) 1582 763133; fax: +44 (0) 1582 763010.
E-mail address: [email protected](J.A. Napier).
Progress in Lipid Research 49 (2010) 108119
Contents lists available at ScienceDirect
Progress in Lipid Research
j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / p l i p r e s
http://dx.doi.org/10.1016/j.plipres.2009.10.001mailto:[email protected]://www.sciencedirect.com/science/journal/01637827http://www.elsevier.com/locate/plipreshttp://www.elsevier.com/locate/plipreshttp://www.sciencedirect.com/science/journal/01637827mailto:[email protected]://dx.doi.org/10.1016/j.plipres.2009.10.0018/12/2019 An Alternative to Fish Oils Metabolic Engineering of Oil-seed Crops to Produce
2/12
1. Introduction
Very long chain polyunsaturated fatty acids (VLC-PUFAs) are
fatty acids of 20 carbons or more in length with three or more
methylene-interrupted double bonds in the cis position. These
fatty acids can be grouped into two main families, omega-6 (or
n-6) and omega-3 (or n-3) families, depending on the position of
the first double bond proximal to the methyl end of the fatty acid.
VLCLC-PUFAs are vital constituents of human metabolism. In par-
ticular, there is plentiful evidence (from epidemiology and dietary
intervention studies) for the health-beneficial properties to hu-
mans of dietary consumption of omega-3 VLC-PUFAs such as eico-
sapentaenoic acid (EPA; 20:5D5,8,11,14,17) and docosahexaenoic
acid (DHA; 22:6D4,7,10,13,16,19) [14]. This dietary requirement
is almost certainly due to the fact that humans (like most animals)
have a very limited capacity to synthesize these fatty acids from
the essential precursor a-linolenic acid (ALA; 18:3D9,12,15) [5];therefore dietary intake of these fatty acids is a key aspect of hu-
man nutrition[6]. The main source of EPA and DHA in the human
diet is through the direct consumption of cold water marine fish
(such as salmon, tuna, mackerel, and sardines) [6,7]. However,
marine fish (like other animals) do not efficiently metabolise ALA
to VLC-PUFAs, but accumulate them as a result of their dietary
acquisition (though it should be noted that freshwater fish appear
to have a greater capacity to synthesize EPA and DHA from ALA)
[7,8]. The primary de novo synthesis sources of VLC-PUFAs are mar-
ine microbes such as algae which form the base of an aquatic food
web that culminates in the accumulation of these fatty acids in the
lipids of the fish [9]. In these microorganisms, EPA and DHA are
synthesized de novoby one of the two classes of biochemical path-
way (reviewed on the text below). In addition, some fungi, mosses,
bacteria and lower plants also have a capacity to synthesize signif-
icant amounts of VLC-PUFAs [10]. In higher plants these fatty acids
are almost completely absent, although plants are rich in the two
essential dietary fatty acids linoleic acid (LA; 18:2D9,12) anda-lin-olenic acid (ALA; 18:3D9,12,15) that serve as the metabolic precur-
sors for VLC-PUFA biosynthesis in animals[11].There is growing concern regarding the sustainability of global
fish stocks (the predominant sources of omega-3 VLC-PUFA) be-
cause marine fish stocks are in severe decline as a result of decades
of over-fishing[12]. Moreover, environmental pollution of marine
ecosystems has resulted in the accumulation of dioxins, heavy
metals and polychlorinated biphenyls in fish, to the point of ques-
tioning the benefits of fish consumption in human health [13]. Fi-
nally, the expansion of industrialised aquaculture exacerbates the
overexploitation of natural marine resources, since farmed fish re-
quire omega-3 VLC-PUFA-containing feedstuffs. The marine oils
used as aquaculture feedstocks are usually extracted from so-
called trash species such as sand eels, which are specifically har-
vested for this application (since they are not normally consumed
by humans). However, the loss of these species from food-webs hasa profound impact on the overall stability of ecosystems [14].
Aquaculture is certainly the largest consumer of fish-derived oils
and currently even the most sophisticated husbandry of high value
species such as salmon require the input of dietary fish oils to a le-
vel significantly higher than that present in the finished product.
Therefore aquaculture is (perhaps surprisingly, at least to the lay-
person) a net consumer of fish oils and as such, not operating in
a sustainable manner. In view of all of these points, there is a very
obvious requirement for an alternative and sustainable source of
VLC-PUFA for their use in human nutrition [1517].
Perhaps the most obvious alternative to fish oils is via contained
culture of the aquatic microbes which synthesize EPA and/or DHA.
Approaches using microbiological sources to synthesize VLC-PUFA
have been developed and are economically viable for specific highvalue applications (such as infant formula baby milk formula-
tions [18]) in controlled culture systems. However, such systems
are expensive to maintain and have limited flexibility for signifi-
cant scale-up and requiring the appropriate microbiological facili-
ties (such as fermenters) [19]. It is noteworthy that such
fermentation-based systems are also sensitive to disruptions of
power-supplies and have a significant environmental footprint.
In view of all these factors, there is an obvious need for an alter-
native, sustainable source of these important fatty acids. Oneattractive option is the use of transgenic plants to synthesize these
fatty acids. Because no higher plant oilseeds produce VLC-PUFAs
such as EPA and DHA, they must be reverse-engineered (the dis-
covery of technological principles through deconstruction and
analysis of component parts)[20]with this biosynthetic capacity
by the introduction of this metabolic pathway from a suitable
microbial source [16,17,20]. During the last ten years, genes encod-
ing the primary enzymes involved in biosynthesis of these fatty
acids have been successfully isolated from a range of VLC-PUFA-
synthesising organisms with a number of these being heterolo-
gously expressed (singly or in combination) in oil-seed crops
[21,22] the promise and the prospects of these new transgenic
crops will be considered in this review.
2. Omega-3 long chain polyunsaturated fatty acids
(x3 LC-PUFAs) in humans health
All animals have lost the capacity to synthesize VLC-PUFAS due
to the genetic absence ofD12 and D15-desaturase activities and, as
a consequence, cannot produce linolenic acid (LA; 18:2D9,12n-6)
anda-linolenic acid (ALA; 18:3D9,12,15 n-3) respectively from theprecursor oleic acid (18:1D9) [23]. However, they do have a lim-
ited ability to synthesize ARA and EPA from these two dietary-
essential fatty acids (EFAs) LA and ALA through a series of desatu-
ration and elongation reactions (Fig. 1) [24]. Most dietary LA and
ALA are b-oxidized to provide energy and only a small portion of
them are converted to VLC-PUFAs [25]. It is estimated that the %
conversion of ALA to EPA is 510%, whereas conversion of ALAto DHA is
8/12/2019 An Alternative to Fish Oils Metabolic Engineering of Oil-seed Crops to Produce
3/12
are ubiquitous in higher plant and play a crucial role in the synthe-
sis of membrane lipids for the support of photosynthesis and also
the precursors for the oxylipin jasmonic acid required for male fer-
tility [22]. The presence of these EFA desaturases has been ob-
served in some lower animals, most notably Caenorhabditis
elegans. Genetic analysis of the role of these enzymes in C. elegans
indicates that they play a vital role in development [34]and such
studies indicate the usefulness of this nematode in studies on the
role of EFAs and VLC-PUFAs in multicellular organisms [35].
VLC-PUFAs are functional components that can modulate mem-
brane fluidity and permeability. As a consequence they play crucial
roles in human metabolism, not only playing structural roles inphospholipid bilayers but also acting as precursors to bioactive
molecules. For example, both omega-6 and omega-3 C20 fatty
acids are precursors of the eicosanoids, oxygenated VLC-PUFA
metabolites involved in the regulation of inflammation, plaque
aggregation, and vasoconstriction/dilation. Both EPA and ARA serve
as substrates for the common cyclooxygenase and lipoxygenase
enzymes; while omega-6 ARA produces more potent inflamma-
tory, pro-aggregatory and inmuno-active eicosanoids (series-2),
eicosanoids derived from omega-3 fatty acids (series-1 and ser-
ies-3) are anti-inflammatory and modulate plaque aggregation
and immune-reactivity[36,37]. Unsurprisingly, research has dem-
onstrated that there are considerable health benefits to be gained
from having a diet rich in VLC-PUFA, and in particular EPA and
DHA. For example, the VLC-PUFAs ARA and DHA play an importantrole in neonatal health and development[3840], in particular the
acquisition of ocular vision and brain development: it is for this
reason that both these fatty acids are recommended for inclusion
in infant formula milks[18]. Clinical trials have demonstrated pro-
tective roles for EPA and DHA in the prevention of cardiovascular
disease and there is also emerging evidence of these VLC-PUFAs
protecting against metabolic syndrome and related disease states,
such as obesity and type-2 diabetes[31,41]. More recently, protec-
tive effects have been clinically studied for cancer[42], atheroscle-
rosis, cognitive impairment, and various mental illness, in
particular depression[29], childhood and attention-deficit hyper-
activity disorder (ADHD)[43,44]and dementia[45]. Finally, there
are epidemiological studies which extend the beneficial effects ofomega-3 VLC-PUFA to the immune system (including diseased
states such as rheumatoid arthritis)[46], the reproductive system,
skin barrier function [47] and other exciting emerging roles such as
inflammation-resolution[48].
3. Characterization of VLC-PUFAs biosynthetic pathways
Over the last decade, all the primary genes involved in VLC-PUFA
biosynthesis have been identified from a range of different species,
including animals, fungi, plants and aquatic organisms. These genes
can be classifiedinto the twodistinct enzymatic reactions that cata-
lyse the primary biosynthetic process. The first of these are the
microsomal fatty acid desaturases, so-called front end PUFA
desaturases which belong to the N-terminal cytochrome b5-fusionsuperfamily, firstly identified in 1997 by Sayanova et al. [49]. The
18:2 9,12Linoleico acid (LA)
18:3 9,12,15-Linolenic acid (ALA)
3 Des
15 Des18:1 9
Oleico acid (OA)
12 Des
18:0
Stearic acid (SA)
9 Des
Plants
Animals
Micobial 4 pathwayMammalian Sprecher
pathway
Conventional 6-pathway
Alternative
8-pathwayAlternative
8-pathway
Fig. 1. Aerobic VLC-PUFA biosynthetic pathways. The various routes for synthesis of arachidonic acid (ARA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) are
shown, as mediated by the consecutive action of desaturases and elongases. The predominant D6-pathway is shown, as is the alternative D8-pathway. Two routes for DHAsynthesis are shown, microbial D4-pathway and mammalian Sprecher pathway. Des = desaturase, Elo = elongase.
110 M. Venegas-Calern et al. / Progress in Lipid Research 49 (2010) 108119
8/12/2019 An Alternative to Fish Oils Metabolic Engineering of Oil-seed Crops to Produce
4/12
cytochrome b5 domain is assumed to be involved in the electron
transport chain required for acyl-desaturation, and currently all
known examples of microsomal VLC-PUFA desaturases contain this
N-terminal extension. This is in contrast to theD12 and D15-desat-
urases found in plants, algae and some fungi which lack any such
cytochrome b5 domain. Another characteristic of the front end
desaturases is thesubstitutionof histidine by glutamine in the third
histidine box (consensus sequence QX[23]HH). The presence
of diagnostic motifs such as a cytocromeb5 domain and this variant
His box have greatly facilitated the identification of candidate
front end desaturases from animals, fungi, and algae, and also
from the few plant species (borage, evening primrose, black currant
andEchium) that carry out D6-desaturationof LA and ALA [50]. One
crucial observation regarding the microsomal desaturases from
lower eukaryotes is that very many of these enzymes utilize glycer-
olipid-linked substrates, in particular fatty acids esterified to the
sn-2 position of glycerolipids. This is not the case in animals, where
the substrates for these enzyme activities are generally believed to
be acyl-CoAs[5153].
The second key enzymatic reaction in the synthesis of VLC-
PUFA is elongation, which also occurs in the ER. The fatty acid elon-
gation reaction consists of four sequencial activities: condensation
of the substrate fatty acid with malonyl-CoA (b-ketoacyl-CoA syn-
thase; KCS), reduction (b-ketoacyl-CoA reductase; KCR), dehydra-
tion (hydroxyacyl-CoA dehydratase; HCD), and a second
reduction (enoyl-CoA reductase; ECR) [54] and resulting in a
two-carbon chain elongation of the input substrate fatty acid.
The condensing enzymes are considered to be rate-limiting and
the regulators of substrate-specificity with regard to chain length
and pattern of double bonds. Perhaps unexpectedly, the expression
of sequences encoding b-ketoacyl-CoA synthase activities alone are
able to reconstitute a heterologous elongating activity without
requirement for the co-expression of any other components of
the elongase[5557]. It is therefore for this reason that KCSs are
often (semantically incorrectly) referred to as elongases. It is as-
sumed that the ability of heterologously expressed KCSs to appar-
ently direct the elongation of substrate fatty acids is due to theinteraction between endogenous core elongase components
(KCR, HCD, ECD) and the exogenous KCS in the absence of any
of these three latter components, elongation cannot occur. It
should be noted that KCS condensing enzymes can be divided into
two distinct groups. A first group comprises the so-called ELO-like
sequences (named after the yeast ELO genes, which are required
for the synthesis of saturated very long chain fatty acids found in
sphingolipids [58]) some of which involved in VLC-PUFA biosyn-
thesis, which have been cloned from a number of species including
mammals, fungi (e.g. Mortierella alpina) [59], and aquatic algae (e.g.
Isochrysis galbana)[60]. A second class of unrelated plant-specific
KCS activities are known as FAE1-like enzymes (so-called after
the founding member of this family, FAE1 fatty acid elongation1,
an Arabidopsis gene required for the synthesis of VLCFAs found inseed triacylglycerols), involved in the biosynthesis of saturated and
monounsaturated fatty acids with C1822+ chain length,[61].
Until very recently, it was believed that FAE-like activities were
restricted to only being involved in the synthesis of saturated and
monounsaturated VLCFAs for use in wax and storage lipid synthe-
sis. However, there is now evidence that this FAE-like class is also
involved in the synthesis of VLC-PUFAs a PUFA-FAE was function-
ally characterised from the parasitic protozoa Perkinsus marinus
[62]. Interestingly, this KCS was in a small gene cluster with two
cytochrome b5-fusion desaturases, and when all three open reading
frames (ORFs) were heterologously expressed in yeast, the synthe-
sis of ARA and EPA was achieved. As noted above, the heterologous
activity of any KCS, be it ELO-like or FAE1-like, is dependent on the
presence of the core elongase components. Although FAE1-likeKCSs are structurallyquite different to ELO-like (500aa, 2 TMs ver-
sus
8/12/2019 An Alternative to Fish Oils Metabolic Engineering of Oil-seed Crops to Produce
5/12
short chain acyl-CoA and an unit of malonyl-CoA, followed by suc-
cessive rounds of reduction, dehydration, reduction, and condensa-
tion, with the acyl chain growing by two-carbon units with each
round. A dehydratase/isomerase from this PKS complex catalyze
the trans- tocis-conversion of the double bonds to form EPA and
DHA. The domains encoding these activities are arranged sequen-
tially on long (2030 kb) open reading frames (ORFs) in bacteria
such as Shewanella andVibrio, and marine protist, as Schizochytrium.
Their expression in yeast and plants has been reported [77] provid-
ing an alternative to the aerobic desaturase/elongase system for
transgenic VLC-PUFA production in plants. Interestingly, this PKS-
like pathway generatesEPA or DHA as free fattyacids, meaning that
these products will most likely requireactivation to CoAto facilitate
their incorporation into lipids [78]. It is also worthy of note that
genomic andbiochemical analysis of lipid biosynthesis in Schizochy-
trium indicated that, in addition to thePKS-like pathway, this organ-
ism also possessed desaturase and elongase activities of the
D6-pathway, but crucially lacked the D12-desaturase activity
(analogous to higher eukaryotes) [79]. The retention of this defec-
tive aerobic pathway was suggested by the authors to represent a
scavenging mechanism by which fatty acids prematurely released
fromthe PKS-like system might undergo further modifications [79].
4. Metabolic engineering to produce VLC-PUFAs in higher plants
Higher plants lack the capacity to synthesize LC-PUFAs, thougha
few taxonomically unrelated phyla can synthesize D6-desaturated
fatty acids (thefirststepon theD6-pathway) such as omega-6c-lin-olenic acid (GLA; 18:3D6,9,12) and omega-3 stearidonic acid (SDA;
18:4D6,9,12,15) [80]. The possibility of using transgenic plants that
have been engineered to synthesize and accumulate VLC-PUFAs in
their storage seed oils has been thoroughly investigated over the
last 15 years. The conversion of native plant fatty acids such as LA
and ALA to VLC-PUFAs requires a minimum of three sequential
non-native enzymatic reactions (e.g. two desaturations and acyl-
CoA elongation) to generate C20 PUFAs such as ARA and EPA. The
last few years have seen considerable progress in the identificationfrom diverse sources (algae, fungi, mosses, plants and mammals) of
genes encoding theprimary VLC-PUFA biosynthetic activities, effec-
tively completingthe first stage of attempts to reverse-engineer this
trait into a heterologous host such as a transgenic plant. Proof-of-
concept demonstration that the VLC-PUFA pathway could function
in a transgenic system was first provided by expression in yeast,
with initial data showing the low accumulation of ARA and EPA
[56,57,81,82]and subsequent experiments (with additional genes)
to generate DHA [59]. Such experiments indicated the feasibility
of transgenic expression of the LC-PUFA biosynthetic pathway in
plants. The possibility of producing VLC-PUFAs in transgenic plants
also became clear fromthe earliest attempts to accumulateGLA and
SDA in oil-seed crops by expression of an individual gene, the
D6-desaturase. Although the first expression of a cyanobacterialD6-desaturase in transgenic tobacco plants [83] resulted in the
accumulation of low levels of these fatty acids, considerable pro-
gress has been made reaching high levels (up to 40%) in several
transgenic plants [49,84,85]. In 2004, three different reports by Qi
et al. [86], Abbadi et al. [87]and Kinney et al. [88]demonstrated
VLC-PUFAbiosynthesis in transgenicplantsby reverseengineering,
although eachutilized distinctstrategies towardthe efficient recon-
stitution of the process. Apart from the important biotechnological
breakthroughs, they also provide some new insights into the bio-
chemical pathways under manipulation and provide useful new
tools for the dissection of the underlying enzymatic reactions.
A diagrammatic summary of the results obtained from the stud-
ies discussed below is shown inFig. 2.
The first study utilizing the alternative pathway was the expres-sion of theIsochrysisC18 D9-elongase[89]in leaves ofArabidopsis
using the constitutive CaMV 35S promoter and resulted in the syn-
thesis of significant levels of EDA and ETriA (15% of total FA) [90].
To fully reconstitute the alternative VLC-PUFA biosynthesis path-
way for ARA and EPA, transgenic Arabidopsis lines expressing the
Isochrysis D9-elongase were sequential transformed with the Eu-
glena D8-desaturase and the M. alpina D5-desaturase [91] under
the control of the constitutive 35S promoter [86]. ARA and EPA
products were accumulated to a combined level of 10% (3% EPA
and 6.6% ARA) of total fatty acids in leaf tissues; these data repre-
sented an important proof-of-concept demonstration [86,92].
Detailed analyses of leaf lipids[90]have confirmed that both D9-
C18-PUFAs were efficiently elongated, accumulating to very high
levels in the acyl-CoA pool of transgenic plants[93]. This indicated
the inefficient transfer of these non-native fatty acids from the
acyl-CoA pool into extra-plastidial phospholipids for their subse-
quent desaturation. In addition to accumulation of ARA and EPA,
several other C20 PUFA were also detected and identified as scia-
donic acid (20:3D5,11,14) and juniperonic acid (20:4D5,11,14,17)
[86]. These two non-methylene-interrupted PUFA appear to have
arisen from the promiscuous activity of the D5-desaturase on
substrates that might be expected to undergo D8-desaturation,
due to a competition between enzymes for the elongated product.
The M. alpina D5-desaturase used in the reconstitution of the alter-
native VLC-PUFA biosynthetic pathway was previously observed to
utilize unexpected substrates when individually expressed in
transgenic canola, resulting in the accumulation of the unusual
D5-desaturated C18 FA, taxoleic and pinolenic acids [91]. It re-
mains to be seen how well the alternative pathway performs when
it is expressed in seeds, as opposed to vegetative tissue.
Complementary studies were described by Abbadi et al. [87]on
the expression of the conventional D6-desaturase pathway in lin-
seed (Linum usitatissimum) and tobacco by coexpressing the D5-
and D6-desaturases from the diatom Phaeodactylum tricornutum
[82] together with the D6-elongase from the moss Physcomitrella
patens under the control of seed-specific promoters and introduced
as a single integration event. Transgenic lines accumulated rela-
tively low levels, only 1.6% EPA and 2.7% ARA. However, whilstthese C20 LC-PUFA were low, very high levels (>25% of total fatty
acids) ofD6-desaturated fatty acids (GLA and SDA) were observed.
This indicated that whilst the first desaturation in the VLC-PUFA
biosynthetic pathway was functioning efficiently, the elongation
step was severely limited. There was a bottleneck, described as
substrate dichotomy [22], as a result of poor acyl-exchange of
GLA and SDA from the phospholipid species from where they were
generated to their acyl-CoA derivatives. The authors suggested that
the linseed acyl-CoA:lyso-phosphatidylcholine acyltransferase
(LPCAT), the enzyme believed to be primarily responsible in medi-
ating acyl-exchange between phosphatidylcholine and the acyl-
CoA pool [94], discriminates against D6-desaturated acyl groups
as substrates. Detailed biochemical and metabolic analysis con-
firmed that this poor exchange resulted in the incorporation ofGLA away from the VLC-PUFA biosynthetic activities, instead being
directly incorporated into TAG in an acyl-CoA-independent man-
ner. This is most likely to result from the direct conversion of phos-
phatidylcholine (PC)-containing GLA to TAG, presumptively via a
strong action of a phospholipid: diacylglycerol acyltransferase
(PDAT)-like activity[87,95]. In respect to the substrate dichotomy
bottleneck observed in linseed, this was analogous to that observed
for the D8-alternative pathway in Arabidopsis [86], with the build-
up of the product of the first enzyme in the pathway. This
presumptively occurred as a result of poor acyl-exchange between
the two metabolic pools (phospholipids, acyl-CoA) through which
VLC-PUFA biosynthesis progresses, and highlights the importance
of acyl-exchange in both the forward (acyl-CoA? PC; required
after the first reaction of the D8-alternative pathway) andreverse (PC? acyl-CoA; required after the first reaction of the
112 M. Venegas-Calern et al. / Progress in Lipid Research 49 (2010) 108119
8/12/2019 An Alternative to Fish Oils Metabolic Engineering of Oil-seed Crops to Produce
6/12
D6-pathway) directions in heterologous VLC-PUFA biosynthesis.
Given that such acyl-exchange is dependent on endogenous acyl-transferases activities accepting non-native substrates (i.e. the
intermediates of VLC-PUFA pathway) it is also likely that different
activities (e.g. lyso-phospholipid acyltransferases, PDAT etc.) havedifferent affinities for these novel fatty acids[96]. Moreover, since
Fig. 2. Overview of oil composition in transgenic lines. The fatty acid compositions of published transgenic lines have been compared, with the levels of target products and
biosynthetic intermediates shown. The different configurations used are indicated. For clarity, the endogenous fatty acids are not shown, since these vary on a species-by-
species basis. The studies compared are: Qi et al. (2004) [86], Abbadi et al. (2004)[87], Kinney et al. (2004) [88], Wu et al. 2005[100], Robert et al. (2005)[102], Hoffmann
et al. (2008)[104]. (A) Omega-3 VLC-PUFA (EPA, DHA) accumulation in transgenic plants. (B) Omega-6 VLC-PUFA (ARA) accumulation in transgenic plants.
M. Venegas-Calern et al./ Progress in Lipid Research 49 (2010) 108119 113
8/12/2019 An Alternative to Fish Oils Metabolic Engineering of Oil-seed Crops to Produce
7/12
many of these acyl-exchange enzymes can work in both forward
and reverse directions, the pool sizes of individual metabolites is
also likely to prove critical in determining the predominant en-
zyme activity.
A third exemplification is described in the patent application by
Kinney et al. [88] realized in soybean (Glycine max). These
researchers used a similar approach to that of Abbadi et al. [87],
expressing genes encoding components of the conventional D6-
desaturase pathway, a D6-desaturase (either from the oomycete
fungusSaprolegnia diclinaorM. alpina), a D6-elongase from M. alp-
ina and finally a D5-desaturase fromM. alpine, in transgenic soy-
bean seeds and somatic embryos. However, to maximize the
accumulation of omega-3 VLC-PUFAs such as EPA and DHA, anAra-
bidopsis FAD3 gene[97]and aS. diclina D17-desaturase[98]were
also co-expressed to turn the omega-6 PUFA metabolites into their
omega-3 counterparts. The expression of these five enzymes
yielded of 19.6% EPA in the transgenic somatic embryos, while al-
most no ARA intermediate was observed because of the presence of
the highly efficient D17-desaturase used. Although the reasons for
the high yields obtained in soybean as compared to linseed are not
clear, the differences between the two studies may be a reflection
on the differing endogenous lipid metabolism present in linseed,
though it should be noted that similar attempts to produce EPA
in transgenic soybeans have been much less successful, for un-
known reasons [99]. The lower accumulation of GLA in soybean
oil, compared with tobacco and linseed, suggests a higher efficient
transfer of GLA to the acyl-CoA pool for subsequent elongation by
the reverse reaction of soybean LPCAT. Unexpectedly, up to 4.7% of
x3-docosapentaenoic acid (DPA; 22:5D7,10,13,16, 19), a DHA pre-cursor, was also detected in the high EPA lines as a result of the
additional activity of the M. alpine D6 elongase toward the D5-
fatty acid EPA. This activity was not previously reported when
the elongase was expressed in yeast [56],demonstrating a differ-
ence in substrate-specificities in plant and yeast. This promiscuity
is worthy of further investigation, and maybe indicates problems
in the correct assembly of the elongase (discussed below). As a re-
sult of the accumulation of DPA, Kinney et al. [88]carried out an-other co-transformation series with six cDNAs to produce DHA in
somatic embryos. Additional genes for the D4-pathway, a D4-
desaturase from the fungusSchizochytrium aggregatum and a spe-
cific D5-elongase from the alga Pavlovasp. were expressed in addi-
tion to the activities required to generate EPA. However, only low
levels of DHA (2.03.3% of total fatty acids) were obtained, most
likely due to the generic problems of substrate dichotomy dis-
cussed above, resulting in inefficient acyl-exchange between the
D5-elongase and the D4-desaturase.
Two additional studies have demonstrated the accumulation of
DHAandEPA inoilseeds. Firstly,Wu et al.[100] describedexpression
oftheD6-pathwayin Brassica junceausing a similarapproachto that
used by Kinney et al.[88]but involving more transgenes. A D17-
desaturase from Phytophtora infestans was introduced to convertomega-6 substrates to omega-3 counterparts, a D12-desaturase
from Calendula officinalis [101] toincrease theflux through theentire
transgenicpathway andfinallya gene encoding a LPCAT from Thrau-
stochytrium sp. was also co-expressed to increase exchange of D6-
unsaturated acyl groups from acyl-phospholipids to acyl-CoAs for
elongation. As a result of the genes co-expression transgenic B. jun-
cea plants accumulated upto 25%ARA or 15%EPA [100]. This highle-
vel of EPAallowed the introduction of the additional genes required
forDHA synthesis(D5-elongase, D4-desaturase) to attempt thecon-
version of EPA to DHA, resulting in low but significant amounts of
DHA (0.21.5% of fatty acids in the seed lipids). These data indicate
thatB. junceais a highly efficient host for the synthesis of ARA and
EPA to high levels (comparable to that observed in soybean) but
capable only of low level synthesis of DHA, reflecting an apparentblockin the conversionof EPA tothe C22 PUFA, DHA.Thiswouldalso
indicatethat whilst endogenous B. juncea acyltransferases can facil-
itate the exchange of acyl-intermediates on the pathway to EPA, the
longer, more unsaturated forms of the DHA pathway are only very
poorly utilized. Thus, the successful accumulation of DHA may re-
quire the co-expression of suitable acyl-exchange activities.
A similar approach was carried out by Robert et al. [102]
expressing a bifunctional D6/D5-desaturase from zebrafish (Danio
rerio)[103]in conjunction with theD6-elongase PEA-1 from C. ele-
gans [57]to generate EPA. To generate DHA, two additional activi-
ties (D5-elongase and D4-desaturase) from the algae Pavlova
salinawere co-expressed [69]. Based on the observations of Abbadi
et al.[87]and subsequent studies, Robert et al. hypothesised that
the use of the (putative) acyl-CoA-dependent desaturase from zeb-
rafish might overcome substrate dichotomy bottlenecks prior to
D4-desaturation. However, whilst this study did demonstrate a
proof-of-concept accumulation of ARA, EPAand DHAin Arabidopsis
seeds, the levels achieved were relativelylow: ARA and EPA (4.2%of
total lipids) and 0.20.5% of DHA. These results could be explained
by lowsubstrate levels of LA-CoAand ALA-CoA in theacyl-CoA pool,
which then rate-limits the levels ofD6-desaturation products and
all subsequent metabolites. Alternatively, the codon usage of the
two animal genes (C. elegans PEA-1 D6-ELO, D. rerio desaturase)
may have resulted in the inefficient translation of these enzyme
activities. Finally, it remains to be demonstrated that the D. rerio
desaturase is indeed abona fide acyl-CoA dependent activity.
These additional studies on the heterologous expression of
desaturase/elongase combinations in different host plant species
demonstrated that minor differences in host plant biochemistry
can be of vital importance on the successful synthesis of ARA and
EPA. Endogenous acyltransferases activities from transgenic soy-
bean and Brassica presumptively have a broader substrate-specific-
ity than linseed or tobacco and can partially overcome thesubstrate
dichotomy problem. A further attempt to avoid the acyl-exchange
bottleneck in transgenicplants by using acyl-CoA-dependent desat-
uraseshasbeen recently described [104]. These authors isolatedand
characterized two cDNAs from the microalga Mantoniella squamata
which encoded for D6- and D5-desaturases with predictedacyl-CoA-substrate dependence (as described previously for a D6-
desaturase from Ostreococcus tauri [105]. These desaturases were
co-expressed under the control of a seed-specific promoter with
the D6-elongase PSE1 of the moss P. patens [106] in Arabidopsis.
Transgenic plants accumulated low but representative amounts of
EPA, and crucially lacked the accumulation of D6-desaturation
products previously observed in earlier studies. Thus, Hoffmann
et al. [104]confirmed the potential of using acyl-CoA-dependent
activities to overcome the problems associated with substrate
dichotomy. However, it is perhaps surprising that this optimal
configuration of the VLC-PUFA pathway yields only low levels of
the target fatty acids (
8/12/2019 An Alternative to Fish Oils Metabolic Engineering of Oil-seed Crops to Produce
8/12
carrier protein(ACP) domains of theDHAsynthase PKS. These seeds
accumulated up to 0.8% DHA with an additional 1.7% DPA n-6. Fur-
ther optimizationof thispathway in commercial oilseeds is ongoing.
5. Crucial issues: optimization the levels of LC-PUFA in
transgenic plants
Although the effective biosynthesis of ARA, EPA and to some ex-
tent DHA has been demonstrated using different approaches in
transgenic plants, the resultant fatty acid compositions and levels
are not equivalent to that found in fish oil. Moreover, in most cur-
rent examples such transgenic plants also contain high levels of
omega-6 and omega-3 metabolic intermediaries. Marine oils, rich
in EPA and/or DHA, are almost completely devoid of omega-6 fatty
acids such as GLA and DHGLA. The goal now is to generate a veg-
etal oil substitute for fish oils optimizing the accumulation of
VLC-PUFAs. Several approaches (discussed below) have been sug-
gested as a result of the studies described in this article. In addi-
tion, these data also provide new insights into our understanding
of plant lipid biochemistry, in particular the channelling of FA into
various different lipids. Outlined below are logical approaches
which might be expected to enhance the accumulation of VLC-PU-
FAs in transgenic plants.
5.1. The identification of superior desaturases
The first approach is to identify highly active acyl-CoA depen-
dent desaturases from a lower eukaryote, as has already been de-
scribed for the D6-desaturase fromO. tauri [105]or M. squamata
[104]. With such enzyme activities, both the desaturation and elon-
gation reactions utilize acyl-CoA substrates and avoid the require-
ment for acyl-exchange with PC. As noted above, published
examples of the use of an acyl-CoA dependent route have resulted
in the significant reduction in the accumulation of biosynthetic
intermediates (most notably omega-6 GLA, linked to PC) but the ac-
tual levels of target VLC-PUFAssuch as EPAand DHAare disappoint-
ingly low [102,104]. This may be due to a number of problems(substrate availability, use of non-optimized sequences) or reflect
additional (undefined) metabolic bottlenecks. It remains to be dem-
onstrated that an exclusively acyl-CoA dependent pathway delivers
significant improvement to yields of EPA or DHA levels, thought it
could also be argued that the unambiguous identification of an
acyl-CoA dependent D5-desaturase from lower eukaryotes is cur-
rently lacking. Very recently, the molecular identification of an
acyl-CoA dependent D12-desaturase was reported from insects
[108]and it will be of interest to see if the co-expression of this
activity would enhance (through the generation of LA-CoA) the
activity of the algal acyl-CoA D6-desaturases in transgenic plants.
A second modification based around desaturation is to ensure
the conversion of omega-6 fatty acids to their omega-3 equivalents
is through the use ofx3-desaturases: such enzyme activities havebeen demonstrated to be pivotal in the production of elevated lev-
els of EPA in Brassica juncea [100]. Such x3-desaturases ideallyhave a high preference for C20 substrates (such as ARA) and have
been identified from a number of fungal species[17]. An alterna-
tive iteration is to identify VLC-PUFA desaturases with strong pref-
erences for omega-3 substrates such as have been identified from
M. squamata, Primula and Echium [104,109,110]. In the case of
the Primula D6-desaturase, expression of this activity in linseed
has recently been shown to result in the significant accumulation
of SDA without the concomitant accumulation of GLA[85]. Another
potentially very useful enzyme activity, a bifunctional D12- and
D15-desaturase, has also recently been described from a number
of organisms by several different groups. Damude et al.[111]iden-
tified such a bifunctional desaturase fromFusarium moniliformeand demonstrated that the co-expression of this activity with the
primary VLC-PUFA biosynthetic enzymes resulted in significant
enhancement of the levels of EPA in both yeast (Y. lipolytica) and
plants (soybean). Similarly, bifunctional desaturases were charac-
terised from the free living amoeba A. castellanii [70], Claviceps
purpurea [112] andCoprinus cinereus [113]. Thus, such activities
have the potential to generate considerable omega-3 substrates
for conversion to LC-PUFAs.
5.2. Identification of a VLC-PUFA-specific acyl-exchange mechanism
Metabolicbottlenecks appear to limit the full potential of oil-
seed crops to accumulate economically sufficient amounts of these
novel fatty acids. Such factors are likely to be represented by en-
zymes involved in thechannelling andpartitioning of fatty acids be-
tween the different metabolic pools involved in lipid synthesis and
compartmentation this can take the form of spatial separation of
different organelles (as is the case for TAG-containing oil bodies)
or exchange between different substrate pools. Central to that latter
problemis theso-called substrate dichotomy, where desaturation
uses acyl-substrateslinkedto phospholipidswhereas elongation re-
quires acyl-CoA substrates. It is predicted that the enzyme LPCAT,
responsible for catalysing bidirectional exchange between these
two pools, could help alleviate this bottleneck (represented sche-
matically in Fig. 3). Very recently, genes encoding LPCAT have been
functionally characterised from yeast and animals (reviewed in
[114]), though in all cases only the forward reaction of LPCAT was
demonstrated (i.e. acyl-CoA-dependent acylation of lyso-PC) (e.g.
[115,116]). Interestingly, two Arabidopsis genes which showed
strong homology to animal LPCATs were shown to encode predom-
inantly LPEAT activities (acyl-CoA-dependent acylation of lyso-PE)
[117]. Thus, the identification of a plant or algal form of LPCAT re-
mains to be demonstrated, as does the role of the reverse reaction
(release of a fatty acid from the sn-2 positions of PC and activation
to acyl-CoA) and its utility in transgenic synthesis of VLC-PUFAs.
5.3. Maintenance of a continuous flux of substrates through the
VLC-PUFA biosynthetic pathway without significant loss to TAG
Technological modifications to endogenous lipid metabolism to
overcome such problem are not obvious, not least of all since such
acyl-channelling represents the sum of multiple different acyl-
exchange activities. In addition, it is highly likely that each plant
G3PATG3P LPA PA DAG
LPAAT PAPPC DAG
DGATTAG
PC pool
CPT CPT
Lyso-PC
LPCAT
Acyl-CoApool
PDAT
LPCAT
Fig. 3. Schematic representation of triacylglycerol synthesis in plants. The acyl-
CoA-dependent (Kennedy) pathway is shown as the central route for TAG synthesis.
The primary activities are shown: acyl-CoA:glycerol-3-phosphate acyltransferases
(G3PAT); acyl-CoA: lyso-phosphatidic acid acyltransferases (LPAAT); phosphatidic
acid phosphatise (PAP); acyl-CoA:diacylglycerol acyltranserase (DGAT). Also shown
are the acyl-CoA-independent activities such as the acyl-transfer between PC and
DAG to generate TAG (catalysed by PDAT this reaction also generates lyso-PC) and
also acyl-exchange between PC and DAG catalysed by cholinephosphotransferase
(CPT). The acyl-CoA pool is generated by export of fatty acids from the plastid, and
represents the sum of this activity plus reverse acyl-exchange from extra-plastidialphospholipids.
M. Venegas-Calern et al./ Progress in Lipid Research 49 (2010) 108119 115
8/12/2019 An Alternative to Fish Oils Metabolic Engineering of Oil-seed Crops to Produce
9/12
species has a different combination of such activities (perhaps evi-
denced by the huge disparity in the composition of plant seed oils),
making a generic intervention unlikely if not impossible. A hypo-
thetical solution might be the identification of TAGbiosynthetic en-
zymes (such as diacylglycerol acyltransferases, DGAT or LPAT)
which have a very strong substrate preferencefor EPAor DHA. How-
ever, such activities are generally acyl-CoA-dependent, meaning
that the substrate VLC-PUFA must be present in the acyl-CoA pool.
The converse solution to this requirement is to use acyl-CoA-inde-
pendent enzymes such PDAT[95], which catalyses the generation
of TAG through the removal of fatty acids from the sn-2 position
of phospholipids and then acylates them to DAG. Such an activity
hastheadvantage of removing desaturation products fromtheirsite
of synthesis, but it appears that PDATs are not restricted to PC as
substrates. Genes for PDAT have been identified in plants, but little
evidence has been found to date to suggest that these enzymes play
a major quantitative or qualitative role in seed TAG metabolism.
However, it may be possible to identify TAG biosynthetic enzymes
from VLC-PUFA-synthesising lower eukaryotes which display the
desired activities. Interestingly, recent evidence from plants has
shown that the DGAT2 class of DGAT displays a more precise range
of substrate-specificities, compared with DGAT1-type enzymes
[118].
5.4. Optimizing the fatty acid elongase
Microsomal fatty acid elongation occurs as a result of four
sequential enzymatic reactions: condensation, ketoreduction,
dehydration andenoyl reduction, although for transgenic is possible
through heterologous expression of just the initial condensing en-
zyme [55,64]. It has been assumedthat the contribution of the other
elongase components to VLC-PUFA synthesis is neutral, since the
condensing enzyme acts in a trans-dominant manner. However, it
is conceivable(if not likely) that the physical andbiochemical inter-
actions between a non-native condensing enzyme and the other
three endogenous elongase components may be sub-optimal. Per-
haps of significance is the fact that in higher plants, unlike yeastor animals, the predominant microsomal KCS activities take the
formof FAE1-like enzymes, whereas the transgenic VLC-PUFA elon-
gating activity is of the ELO-like form [63]. In that respect the atyp-
ical FAE1-like alternative pathway D9-elongating activity isolated
fromP. marinus [62]may warrant further evaluation, as might the
search for additional examples of FAE1-like VLC-PUFA elongating
activities. Alternatively, the use of (ELO-like) activities from VLC-
PUFA-synthesising lower plants such as Marchantia polymorpha
may prove of benefit initial studies indicate that M. polymorpha
activities perform well in transgenic plants [119]. Currently, our
understanding of the regulation, organisation and assembly of the
elongase complexis limited. Overexpression of theelongase ketore-
ductaseresulted in an increasein theaccumulationof VLCmonosat-
urated fatty acids in yeast, presumably by either increasing fluxthrough theelongase or increasingthe absolutenumber of elongase
complexes, challenging the concept that the core elongase com-
ponents have a neutral role in determining the levels of VLCFAs
[120]. Thus, for all of the reasons outlined above, it may be that to
obtain maximal elongation of target fatty acids, the additional core
components of the elongases may need to be isolated from suitable
EPA- or DHA-accumulating organisms and co-expressed with the
transgene condensing enzyme from the same species.
5.5. Modulating the acyl-CoA pool
As discussed above, the use of acyl-CoA dependent desaturases
is predicted to bypass the metabolic bottleneck generated by sub-
strate dichotomy between the desaturase and the elongase. Thesuccess of this approach is dependent on significant levels of sub-
strate fatty acids (LA, ALA) being present in the extra-plastidial
acyl-CoA pool; given that the acyl-CoA pool in most plant cells is
considered to be lower than that found in yeast or animals [121],
this also indicates the requirement for a strong flux of fatty acids
into this metabolic pool. One proven method for alteringthe profile
of fatty acids present in the acyl-CoA pool is via the use of plastidial
thioesterases which prematurely release fatty acids from the fatty
acid synthase such approaches have been shown to generate in-
creased levels of medium chain acyl-CoAs on expression of a Cuphea
thioesterase [121]. However, it is not obvious how such approaches
would directly result in the enhanced synthesis of VLC-PUFAs.
Alternatively, it has recently been shown that blocking the peroxi-
somal ABC transporter CTS (required for beta-oxidation) results in
elevated levels of cytosolic acyl-CoAs and their incorporation into
storage lipid [122]. Whilst a total blockade of beta-oxidation results
in abnormal plant development and impaired germination, it may
be possible to use developmentally-regulated silencing of such
activities to modulate the acyl-CoA pool, increasing both the sub-
strates available for VLC-PUFA biosynthesis and also the accumula-
tion of target fatty acids in storage triacylglycerols. It must also be
noted that our understanding of the flux of fatty acids into the acyl-
CoA is partial, with very recent studies questioning the established
model in which the products of the plastidial fatty acid synthase
(16:0, 18:0, 18:1) are directly exported from the plastid into the
cytosolic acyl-CoA pool [123]. Similarly, detailed kinetic analysis
of the channelling of fatty acids into soybean embryo triacylglyce-
rols indicates the central of acyl-exchange between PC and the
acyl-CoA pool [124]. Thus, further research on the biosynthesis
and homeostasis of the acyl-CoA pool is required.
5.6. Co-ordinated expression of transgenes
All of theexamples described above of theproduction of VLC-PU-
FAs in transgenic plants have relied on the simultaneous co-expres-
sion of desaturases and elongases in developing seeds. In most
cases, the promoters used to drive this seed-specific expression
were derived not from genes involved in oil biosynthesis but more
often instead from storage protein synthesis. Thus, it may be possi-
ble to enhance the overall levels of target VLC-PUFAs through the
use of promoterswhose activity coincides with maximal oil synthe-
sis and accumulation. Certainly the choice of appropriate promoter
has been postulated to play a key role in the wide variation in VLC-
PUFAs levels observed in transgenic soybeans[17,99].
5.7. Appropriate localisation of transgene-derived activities
It is now believed likely that many microsomal biochemical
reactions occur in discrete sub-domains of the endomembrane sys-
tem. Such sub-domains could be generated by local variation in li-
pid compositions (such as so-called lipid rafts [125]) or via
proteinprotein interaction to nucleate higher-order structures
[126]. In either scenario, it is envisaged that multiple enzyme
activities for a particular biochemical pathway are co-located,
resulting in the minimal loss of intermediates and the optimal
channelling of products to their intended metabolic pool. One pos-
sible reason for limited production of non-native fatty acids such
as VLC-PUFAs could be due to lack of sub-domain co-location for
critical activities this could be either primary biosynthetic en-
zymes or those involved in the generation of a strong flux (i.e. acyl-
transferases such as DGAT[126].
6. Conclusions and future perspectives
It is obvious from the studies described in this article that het-erologous reconstitution of VLC-PUFA synthesis in transgenic
116 M. Venegas-Calern et al. / Progress in Lipid Research 49 (2010) 108119
8/12/2019 An Alternative to Fish Oils Metabolic Engineering of Oil-seed Crops to Produce
10/12
8/12/2019 An Alternative to Fish Oils Metabolic Engineering of Oil-seed Crops to Produce
11/12
[20] Napier JA, Beaudoin F, Michaelson LV, Sayanova O. The production of long
chain polyunsaturated fatty acids in transgenic plants by reverse-
engineering. Biochimie 2004;86:78592.
[21] Sayanova OV, Napier JA. Eicosapentaenoic acid: biosynthetic routes and the
potential for synthesis in transgenic plants. Phytochemistry 2004;65:14758.
[22] Napier JA. The production of unusual fatty acids in transgenic plants. Ann Rev
Plant Biol 2007;58:295319.
[23] Nakamura MT, Nara TY. Structure, junction and dietary regulation of delta6,
delta5 and delta9 desaturases. Ann Rev Nutr 2004;24:34576.
[24] Nakamura MT, Nara TY. Essential fatty acid synthesis and its regulation in
mammals. Prostagland Leukot Essent Fatty Acids 2003;68:14550.[25] Huang YS, Pereira SL, Leonard AE. Enzymes for transgenic biosynthesis of
long-chain polyunsaturated fatty acids. Biochimie 2004;86:7938.
[26] Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA, et al.
Origins and evolution of the Western diet: health implications for the 21st
century. Am J Clin Nutr 2005;81:34154.
[27] Simopoulos AP. Essential fatty acids in health and chronic disease. Am J Clin
Nutr 1999;70:560S9S.
[28] Harris WS, Kris-Etherton PM, Harris KA. Intakes of long-chain omega-3 fatty
acid associated with reduced risk for death from coronary heart disease in
healthy adults. Curr Atheroscler Rep 2008;10:5039.
[29] Horrobin DF. Interactions between n-3 and n-6 essential fatty acids (EFAs) in
the regulation of cardiovascular disorders and inflammation. Prostagland
Leukot Essent Fatty Acids 1991;44:12731.
[30] Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential
fatty acids. Biomed Pharmacother 2002;56:36579.
[31] Nugent AP. The metabolic syndrome. Nutr Bull 2004;29:3643.
[32] Kris-Ethertona PM, Griegera JA, Ethertonb TD. Dietary reference intakes for
DHA, EPA. Prostagland Leuk Essent Fatty Acids 2009;81:99104.
[33] Calder PC, Yaqoob P. Omega-3 polyunsaturated fatty acids and human health
outcomes. Biofactors 2009;35:26672.
[34] Watts JL, Browse J. Genetic dissection of polyunsaturated fatty acid synthesis
inCaenorhabditis elegans. Proc Natl Acad Sci USA 2002;99:58549.[35] Watts JL. Fat synthesis and adiposity regulation in Caenorhabditis elegans.
Trends Endocrinol Metab 2009;20:5865.
[36] Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology.
Science 2001;294:18715.
[37] Tapiero H, Ba GN, Couvreur P, Tew KD. Polyunsaturated fatty acids (PUFA)
and eicosanoids in human health and pathologies. Biomed Pharmacoth
2002;56:21522.
[38] Horrocks LA, Yeo YK. Health benefits of docosahexaenoic acid (DHA).
Pharmacol Res 1999;40:21125.
[39] Innis SM. The role of dietary n-6 and n-3 fatty acids in the developing brain.
Dev Neurosci 2000;22:47480.
[40] Voigt RG, Jensen CL, Fraley JK, Rozelle JC, Brown FR, Heird WC. Relationship
between omega-3 long-chain polyunsaturated fatty acid status during early
infancy and neurodevelopmental status at 1 year of age. J Hum Nutr Diet
2000;15:11120.[41] Das UN. The lipids that matter from infant nutrition to insulin resistance.
Prostagland Leuk Essent Fatty Acids 2002;67:112.
[42] Rose DP, Connolly JM. Omega-3fatty acids as cancer chemopreventive agents.
Pharmacol Ther 1999;83:21724.
[43] Bell JG, Sargent JR, Tocher DR, Dick JR. Red blood cell fatty acid compositions
in a patient with autistic spectrum disorder: a characteristic 32 abnormality
in neurodevelopmental disorders? Prostagland Leuk Essent Fatty Acids
2000;63:215.
[44] Richardson AJ, Puri BK. A randomized double-blind, placebo-controlled study
of the effects of supplementation with highly unsaturated fatty acids on
ADHD-related symptoms in children with specific learning difficulties. Prog
Neuro-Psychopharmacol Biol Psychiatry 2002;26:2339.
[45] Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Wilson RS, et al.
Consumption of fish and n-3 fatty acids and risk incident Alzheimer disease.
Arch Neurol 2003;60:9406.
[46] Navarro E, Esteve M, Oliv A, Klaassen J, Cabr E, Tena X, et al. Abnormal fatty
acid pattern in rheumatoid arthritis. A rationale for treatment with marine
and botanical lipids. J Rheumatol 2000;27:298303.
[47] Horrobin DF. Medical roles of metabolites of precursor EFAs. INFORM1995;6:42835.
[48] Schwab JM, Chiang N, Arita M, Serhan CN. Resolvin E1 and protectin D1
activate inflammation-resolution programmes. Nature 2007;447:86974.
[49] Sayanova O, Smith MA, Lapinskas P, Stobart AK, Dobson G, Christie WW, et al.
Expression of a borage desaturase cDNA containing an N-terminal
cytochrome b5 domain results in the accumulation of high levels of 6-
desaturated fatty acids in transgenic tobacco. Proc Natl Acad Sci USA
1997;94:42116.
[50] Napier JA, Sayanova O, Stobart AK, Shewry PR. A new class of cytochrome b5
fusion proteins. Biochem J 1997;328:7178.
[51] Stymne S, Appelqvist LA. The biosynthesis of linoleate from oleoyl-CoA via
oleoyl-phosphatidylcholine in microsomes of developing safflower seeds. Eur
J Biochem 1978;90:2239.
[52] Griffiths G, Stobart AK, Stymne S. 6- and 12-desaturase activities and
phosphatidic acid formation in microsomal preparations from the
developing cotyledons of common borage (Borago officinalis). Biochem J1988;252:6417.
[53] Jackson FM, Fraser TC, Smith MA, Lazarus C, Stobart AK, Griffiths G.Biosynthesis of C18 polyunsaturated fatty acids in microsomal membrane
preparations from the filamentous fungusMucor circinelloides. Eur J Biochem1998;252:5139.
[54] Fehling E, Lessire R, Cassagne C, Mukherjee KD. Solubilization and partial
purification of constituents of acyl-CoA elongase from Lunaria annua. BiochimBiophys Acta 1992;1126:8894.
[55] Millar AA, Kunst L. Very-long-chain fatty acid biosynthesis is controlled
through the expression and specificity of the condensing enzyme. Plant J
1997;12:12131.
[56] Parker-Barnes JM, Das T, Bobik E, Leonard AE, Thurmond JM, Chuang L, et al.
Identification and characterization of an enzyme involved in the elongation of
n-6 and n-3 polyunsaturated fatty acid. Proc Natl Acad Sci USA2000;97:82849.
[57] Beaudoin F, Michaelson L, Hey S, Lewis M, Shewry P, Sayanova O, et al.
Heterologous reconstitution in yeast of the polyunsaturated fatty acid
biosynthetic pathway. Proc Natl Acad Sci USA 2000;97:64216.
[58] Oh CS, Toke DA, Mandala S, Martin CE. ELO2 and ELO3, homologues of the
Saccharomyces cerevisiaeELO1 gene, function in fatty acid elongation and arerequired for sphingolipid formation. J Biol Chem 1997;272:1737684.
[59] Meyer A, KirschH, Domergue F, Abbadi A, Sperling P, Bauer J, et al. Novelfatty
acid elongases and their use for the reconstitution of docosahexaenoic acid
biosynthesis. J Lipid Res 2004;45:1899909.
[60] Qi B, Beaudoin F, Fraser T, Stobart AK, Napier JA, Lazarus CM. Identification of
a cDNA encoding a novel C189 polyunsaturated fatty acid-specific
elongating activity from the docosahexaenoic acid (DHA)-producing
microalga,Isocarysis galbana. FEBS Lett 2002;510:15965.[61] James DW, Lim Jr E, Keller J, Plooy I, Ralston E, Dooner HK. Directed tagging of
the Arabidopsis FATTY ACID ELONGATION1 (FAE1) gene with the maize
transposon activator. Plant Cell 1995;7:30919.
[62] Venegas-Calern M, Beaudoin F, Sayanova O, Napier JA. Cotranscribed genes
for long chain polyunsaturated fatty acid biosynthesis in the protozoon
Perkinsus marinus contain a plant-like FAE1 3-ketoacyl-CoA synthase. J BiolChem 2007;282:29963000.
[63] Joubs J, Raffaele S, Bourdenx B, Garcia C, Laroche-Traineau J, Moreau P, et al.
The VLCFA elongase gene family in Arabidopsis thaliana: phylogeneticanalysis, 3D modelling and expression profiling. Plant Mol Biol
2008;67:54766.
[64] Paul S, Gable K, Beaudoin F, Cahoon E, Jaworski J, Napier JA, et al. Members of
the Arabidopsis FAE1-like 3-ketoacyl-CoA synthase gene family substitute for
theElop proteins ofSaccharomyces cerevisiae. J Biol Chem 2006;281:901829.[65] Jakobsson A, Westerberg R, Jacobsson A. Fatty acid elongases in mammals:
their regulation and roles in metabolism. Prog Lipid Res 2006;45:23749.
[66] Wallis JG, Watts JL, Browse J. Polyunsaturated fatty acid synthesis: what will
they think of next? Trends Biochem Sci 2002;27:467.
[67] Korn ED. The fatty acids ofEuglena gracilis. J Lipid Res 1964;5:35262.[68] Wallis JG,Browse J. The 8-desaturaseofEuglena gracilis: an alternatepathway
for synthesis of 20-carbon polyunsaturated fattyacids. Arch Biochem Biophys
1999;365:30716.
[69] Zhou XR, Robert SS, Petrie JR, Frampton DM, Mansour MP, Blackburn SI, et al.Isolation and characterization of genes from the marine microalgaPavlovasalina encodingthree front-end desaturases involved in docosahexaenoic acidbiosynthesis. Phytochemistry 2007;68:78596.
[70] Sayanova O, Haslam R, Guschina I, Lloyd D, Christie WW, Harwood JL, et al. A
bifunctional 12, 15-desaturase from Acanthamoeba castellanii directs thesynthesis of highly unusual n-1 series unsaturated fatty acids. J Biol Chem
2006;281:3653341.
[71] Qiu X. Biosynthesis of docosahexaenoic acid (DHA, 22:64, 7, 10, 13, 16, 19):
twodistinct pathways. Prostagland Leukot Essent Fatty Acids 2003;68:1816.
[72] Sprecher H, Chen Q, Yin FQ. Regulation of the biosynthesis of 22:5 n-6 and
22:6 n-3: a complex intracellular process. Lipids 1999;34:S1536.
[73] Meyer A, Cirpus P, Ott C, Schlecker R, Zahringer U, Heinz E. Biosynthesis of
docosahexaenoic acid in Euglena gracilis: Biochemical and molecular evidencefor the involvement of a D4-fatty acyl group desaturase. Biochemistry
2003;42:977988.
[74] Pereira SL, Leonard AE, Huang YS, Chuang LT, Mukerji P. Identification of two
novel microalgal enzymes involved in the conversion of the omega-3-fatty
acid, eicosapentaenoic acid, into docosahexaenoic acid. Biochem J
2004;384:35766.[75] Napier JA. Plumbing the depths of PUFA biosynthesis: a novel polyketide
synthase-like pathway frommarine organisms. Trends Plant Sci 2002;7:514.
[76] Metz JG, Roessler P, Facciotti D, Levering C, Dittrich F, Lassner M, et al.
Production of polyunsaturated fatty acids by polyketide synthases in both
prokaryotes and eukaryotes. Science 2001;293:2903.
[77] Metz JG, Flatt JH, Kuner JM. PUFA polyketide synthase systems and uses
thereof. Martek Biosciences Corporation WO 2006/135866 A2; 2006.
[78] Metz JG,Kuner J, Rosenzweig B, Lippmeier JC, Roessler P, ZirkleR. Biochemical
characterization of polyunsaturated fatty acid synthesis in Schizochytrium:release of the products as free fatty acids. Plant Physiol Biochem
2009;47:4728.
[79] Lippmeier JC, Crawford KS, Owen CB, Rivas AA, Metz JG, Apt KE.
Characterization of both polyunsaturated fatty acid biosynthetic pathways
inSchizochytrium sp.. Lipids 2009;44:62130.[80] Sayanova O, Napier JA, Shewry PR. 6-Unsaturated fatty acids in species and
tissues of the Primulaceae. Phytochemistry 1999;52:41922.
[81] Das T, Thurmond JM, Bobik E, Leonard AE, Parker-Barnes JM, Huang YS, et al.
Polyunsaturated fatty acid-specific elongation enzymes. Biochem Soc Trans2000;28:65860.
118 M. Venegas-Calern et al. / Progress in Lipid Research 49 (2010) 108119
8/12/2019 An Alternative to Fish Oils Metabolic Engineering of Oil-seed Crops to Produce
12/12
[82] Domergue F, Lerchl J, Zahringer U, Heinz E. Cloning and functional char-
acterization ofPhaeodactylum tricornutumfront-end desaturases involved ineicosapentaenoic acid biosynthesis. Eur J Biochem 2002;269:410513.
[83] Reddy AS, Thomas TL. Expression of a cyanobacterial 6-desaturase gene
results in gamma-linolenic acid production in transgenic plants. Nat
Biotechnol 1996;14:63942.
[84] Hong H, Datla N, Reed DW, Covello PS, MacKenzie SL, Qiu X. High-level
production ofc-linolenic acid inBrassica juncea using a D6 desaturase fromPythium irregulare. Plant Physiol 2002;129:35462.
[85] Ruiz-Lpez N, Haslam RP, Venegas-Calern M, Larson TR, Graham IA, Napier
JA, et al. The synthesis and accumulation of stearidonic acid in transgenicplants: a novel source of heart-healthy omega-3fatty acids. Plant Biotechnol
J 2009;7:70416.
[86] Qi B, Fraser T, Mugford S, Dobson G, Sayanova O, Butler J, et al. Production of
very long chain polyunsaturated omega-3 and omega-6 fatty acids in plants.
Nat Biotechnol 2004;22:73945.
[87] Abbadi A, Domergue F, Bauer J, Napier JA, Welti R, Zhringer U, et al.
Biosynthesis of very-long-chain polyunsaturated fatty acids in transgenic
oilseeds: constraints on their accumulation. Plant Cell 2004;16:273448.
[88] Kinney AJ, Cahoon EB, Damude HG, Hitz WD, Kolar CW, Liu ZB. Production of
very long chain polyunsaturated fatty acids in oilseed plants. WO 2004/
071467 A2; 2004.
[89] Qi B, Beaudoin F, Fraser T, Stobart AK, Napier JA, Lazarus CM. Identification of
a cDNA encoding a novel C18-D9 polyunsaturated fatty acid-specific
elongating activity from the docosahexaenoic acid (DHA)-producing
microalga,Isochrysis galbana. FEBS Lett 2002;510:15965.[90] Fraser TCM, Qi B, Elhussein S, Chatrattanakunchai S, Stobart AK, Lazarus CM.
Expression of the isochrysis C18-D9 polyunsaturated fatty acid specific
elongase component alters arabidopsis glycerolipid profiles. Plant Physiol
2004;135:85966.
[91] Knutzon DS, Thurmond JM, Huang Y, Chaudhary S, Bobik Jr EG, Chan GM,
et al. Identification of 5-desaturase from Mortierella alpina by heterologousexpression in bakers yeast and canola. J Biol Chem 1998;273:293606.
[92] Green AG. From alpha to omega-producing essential fatty acids in plants. Nat
Biotechnol 2004;22:6802.
[93] Sayanova O, Haslam R, Qi B, Lazarus CM, Napier JA. The alternative pathway
C20 8-desaturase from the non-photosynthetic organism Acanthamoebacastellanii is an atypical cytochrome b5-fusion desaturase. FEBS Lett2006;580:194652.
[94] Stymne S, Stobart AK. Evidence for the reversibility of the acyl-
CoA:lysophosphatidylcholine acyltransferase in microsomal preparations
from developing safflower (Carthamus tinctorius L.) cotyledons and rat liver.Biochem J 1984;223:30514.
[95] Dahlqvist A, Stahl U, Lenman M, Banas A, Lee M, Sandager L, et al.
Phospholipid:diacylglycerol acyltransferase: an enzyme that catalyzes the
acyl-CoA-independent formation of triacylglycerol in yeast and plants. Proc
Natl Acad Sci USA 2000;97:648792.
[96] Dyer JM, Stymne S, Green AG, Carlsson AS. High-value oils fromplants. Plant J2008;54:64055.
[97] Yadav NS, Wierzbicki A, Aegerter M, Caster CS, Prez-Grau L, Kinney AJ, et al.
Cloning of higher plant omega-3 fatty acid desaturases. Plant Physiol
1993;103:46776.
[98] Pereira SL, Huang YS, Bobik EG, Kinney AJ, Stecca KL, Packer JC, Mukerji P. A
novel omega3-fatty acid desaturase involved in the biosynthesis of
eicosapentaenoic acid. Biochem J 2004;378:66571.
[99] Chen R, Matsui K, Ogawa M, Oe M, Ochiai M, Kawashima H. Expression ofD6,
D5 desaturase and GLELO elongase genes from Mortierella alpina forproduction of arachidonic acid in soybean [Glycine max (L.) Merrill] seeds.Plant Sci 2006;170:399406.
[100] Wu G, Truksa M, Datla N, Vrinten P, Bauer J, Zank T, et al. Stepwise
engineering to produce high yields of very long-chain polyunsaturated fatty
acids in plants. Nat Biotechnol 2005;23:10137.
[101] Qiu X, Reed DW, Hong H, MacKenzie SL, Covello PS. Identification and
analysis of a gene fromCalendula officinalis encoding a fatty acid conjugase.Plant Physiol 2001;125:84755.
[102] Robert SS, Singh SP, Zhou X-R, Petrie JR, Blackburn SI, Mansour PM, et al.
Metabolic engineering of Arabidopsis to produce nutritionally importantDHA in seed oil. Funct Plant Biol 2005;32:4739.
[103] Hastings N, Agaba M, Tocher D, Leaver M, Dick J, Sargent JR, et al. A vertebrate
fatty acid desaturase with D5 and D6 activities. Proc Natl Acad Sci USA
2001;98:143049.
[104] Hoffmann M, Wagner M, Abbadi A, Fulda M, Feussner I. Metabolic
engineering of omega3-very long chain polyunsaturated fatty acid
production by an exclusively acyl-CoA-dependent pathway. J Biol Chem
2008;283:2235262.
[105] Domergue F, Abbadi A, Zahringer U, Moreau H, Heinz E. In vivo
characterization of the first acyl-CoA D6-desaturase from a member of the
plant kingdom, the microalga Ostreococcus tauri. Biochem J2005;389:48390.
[106] Zank TK, Zahringer U, Beckmann C, Pohnert G, Boland W, Holtorf H, et al.
Cloning and functional characterisation of an enzyme involved in the
elongation of 6-polyunsaturated fatty acids from the moss Physcomitrellapatens. Plant J 2002;31:25568.
[107] Metz JG, Flatt JH, Kuner JM. The egenes for the enzymes of the
polyunsaturated fatty acid polyketide synthase ofSchizochytrium and their
use in the manufacture of polyunsaturated fatty acids. International PatentPublication WO 2006135866; 2006.
[108] Zhou XR, Horne I, Damcevski K, Haritos V, Green A, Singh S. Isolation and
functional characterization of two independently-evolved fatty acid 12-
desaturase genes from insects. Insect Mol Biol 2008;17:66776.
[109] Sayanova OV, BeaudoinF, Michaelson LV, Shewry PR, Napier JA. Identification
of primula fatty acid 6-desaturases with n-3 substrate preferences. FEBS Lett
2003;542:1004.
[110] Garca-Maroto F, Maas-Fernndez A, Garrido-Crdenas JA, Alonso DL.
Substrate specificity of acyl-6-desaturases from Continental versus
Macaronesian echiumspecies. Phytochemistry 2006;67:5404.[111] Damude HG, Zhang H, Farrall L, Ripp KG, Tomb J-F, Hollerbach D, et al.
Identification of bifunctional 12/3 fatty acid desaturases for improving the
ratio of 36 fatty acids in microbes and plants. PNAS 2006;103:944651.
[112] Meesapyodsuk D, Reed DW, Covello PS, Qiu X. Primary structure,
regioselectivity, and evolution of the membrane-bound fatty acid
desaturases ofClaviceps purpurea. J Biol Chem 2007;282:201919.[113] Zhang S, Sakuradani E, Ito K, Shimizu S. Identification of a novel bifunctional
12/15 fatty acid desaturase from a basidiomycete,Coprinus cinereusTD#8222. FEBS Lett 2007;581:3159.
[114] Sthl U, Stlberg K, Stymne S, Ronne H. A family of eukaryotic
lysophospholipid acyltransferases with broad specificity. FEBS Lett
2008;582:3059.
[115] Chen X, Hyatt BA, Mucenski ML, Mason RJ, Shannon JM. Identification and
characterization of a lysophosphatidylcholine acyltransferase in alveolar type
II cells. Proc Natl Acad Sci USA 2006;103:117249.
[116] Nakanishi H, Shindou H, Hishikawa D, Harayama T, Ogasawara R, Suwabe A,
et al. Cloning and characterization of mouse lung-type acyl-
CoA:lysophosphatidylcholine acyltransferase 1 (LPCAT1). Expression in
alveolar type II cells and possible involvement in surfactant production. J
Biol Chem 2006;281:201407.
[117] Stlberg K, Sthl U, Stymne S, Ohlrogge J. Characterization of two Arabidopsis
thaliana acyltransferases with preference for lysophosphatidylethanolamine.
BMC Plant Biol 2009;9:60.
[118] Burgal J, Shockey J, Lu C, Dyer J, Larson T, Graham I, et al. Metabolic
engineering of hydroxy fatty acid production in plants: RcDGAT2 drives
dramatic increases in ricinoleate levels in seed oil. Plant Biotechnol J
2008;6:81931.[119] Kajikawa M, Matsui K, Ochiai M, Tanaka Y, Kita Y, Ishimoto M, et al.
Production of arachidonic and eicosapentaenoic acids in plants using
bryophyte fatty acid 6-desaturase, 6-elongase, and 5-desaturase genes.
Biosci Biotechnol Biochem 2008;72:43544.
[120] Beaudoin F, Gable K, Sayanova O, Dunn T, Napier JA. A Saccharomycescerevisiaegene required for heterologous fatty acid elongase activity encodesa microsomal beta-keto-reductase. J Biol Chem 2002;277:114818.
[121] Larson TR, Graham IA. A novel technique for the sensitive quantification of
acyl CoA esters from plant tissues. Plant J 2001;25:11525.
[122] Slocombe SP, Cornah J, Pinfield-Wells H, Soady K, Zhang Q, Gilday A, et al. Oil
accumulation in leaves directed by modification of fatty acid breakdown and
lipid synthesis pathways. Plant Biotechnol J 2009;7:694703.
[123] Bates PD, Ohlrogge JB, Pollard M. Incorporation of newly synthesized fatty
acids into cytosolic glycerolipids in pea leaves occurs via acyl editing. J Biol
Chem 2007;282:3120616.
[124] Bates PD, Durrett TP, Ohlrogge JB, Pollard M. Analysis of acyl fluxes through
multiple pathways of triacylglycerol synthesis in developing soybean
embryos. Plant Physiol 2009;150:5572.
[125] Borner GH, Sherrier DJ, Weimar T, Michaelson LV, Hawkins ND, Macaskill A,et al. Analysis of detergent-resistant membranes in Arabidopsis. Evidence for
plasma membrane lipid rafts. Plant Physiol 2005;137:10416.
[126] DyerJM, Mullen RT. Engineering plantoils as high-value industrialfeedstocks
for biorefining: the need for underpinning cell biology research. Physiol Plant
2008;132:1122.
[127] Kalaitzandonakes N, Alston JM, Bradford KJ. Compliance costs for regulatory
approval of new biotech crops. Nat Biotechnol 2007;25:50911.
[128] Cressey D. Aquaculture: future fish. Nature 2009;458:398400.
M. Venegas-Calern et al./ Progress in Lipid Research 49 (2010) 108119 119